✦ LIBER ✦

16 Transfusion costs associated with use of Gemcitabine-Carboplatin in the treatment of incurable non small cell lung cancer (NSCLC)

✍ Scribed by Abdul Razak, A.R.; Chhabra, R.; Nielson, A.; Dobson, J.; McMenemin, R.; Gardiner, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The development of gemcitabine and carbo

✍ Cullen, M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 197 KB

15 Use of blood transfusions in patients

✍ Tufail, A.; Latif, M.F.; Imran, M.; Wong, H.; Littler, J.; Maguire, J.; Siva, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Combination of docetaxel and gemcitabine

✍ Jensen, N.V.; Hansen, O.; Rose, C. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Healthcare outcomes: gemcitabine cost-ef

✍ Szczepura, Ala 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 455 KB

Gemcitabine and carboplatin in the treat

✍ Chai-Hooi LEOW; Chong-Kin LIAM 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Front line chemotherapy with four differ

✍ S.C. Stani; E. Bajetta; D. De Candis; P. Pozzi; E. Ferrario; D. Cortinovis; L. M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB